Inpatient Opioid Utilisation and Pain Status at Discharge in a Tertiary Hospital in Western Nepal: A Cross-Sectional Study
Pharmaceuticals · 17.11.2026 · 19 (11) · 1826
DOI: 10.3390/ph19111826 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Pharmaceuticals, online erschienen am 17.11.2026. Verfasst von Bhuvan KC und 7 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Evidence describing inpatient opioid utilisation in Nepal remains limited. This study evaluated opioid utilisation patterns, concurrent analgesic use, and pain status at discharge among hospitalised patients receiving opioid therapy in a tertiary care hospital in Western Nepal.
Methods
This hospital-based cross-sectional study included 400 adult inpatients who received at least one opioid analgesic during hospitalisation at a tertiary care hospital in Western Nepal. Outcome measures included patterns of opioid administration, individual opioids used, concurrent non-steroidal anti-inflammatory drugs (NSAID) use, analgesic use before admission, and pain status at discharge.
Results
The mean age of participants was 44.8 years (SD 18.3), and 70.5% were female. Before admission, only 1.3% reported opioid use. During hospitalisation, pethidine was the most frequently used opioid, received by 80.0% of participants, followed by tramadol (27.3%), codeine-containing preparations (5.3%), and fentanyl (4.8%); some patients received more than one opioid. STAT administration was the predominant opioid administration pattern (64.3%), followed by regular scheduled administration (24.5%) and as-required (PRN/SOS) administration (11.3%). Concurrent NSAID use was recorded in 68.3% of patients. The mean pain score at discharge was 3.24 (SD 1.28); 58.0% of patients had mild, 39.3% moderate, and 2.8% severe pain. In an exploratory unadjusted analysis, the distribution of discharge pain severity differed between patients receiving opioids with and without concurrent NSAIDs (χ2 = 6.018, df = 2, p = 0.049).
Conclusions
Inpatient opioid utilisation in this tertiary hospital was characterised by very low reported opioid use before admission, predominant use of pethidine, frequent STAT administration, and common concurrent NSAID use. Most patients had mild pain at discharge, although moderate pain remained common. Because baseline pain severity, treatment indication, and other important clinical variables were unavailable, this study cannot determine prescribing appropriateness or comparative analgesic effectiveness. These findings provide important baseline evidence on inpatient opioid utilisation in Nepal and may inform future prospective research, quality-improvement activities, and context-appropriate opioid stewardship.
Zitieren
APA
KC, B., Adhikari, S., Gurung, R., Kaphle, H. P., Sharma, P., Lamshal, R., Shrestha, S., & Alrasheedy, A. A. (2026). Inpatient Opioid Utilisation and Pain Status at Discharge in a Tertiary Hospital in Western Nepal: A Cross-Sectional Study. Pharmaceuticals, 19(11), 1826. https://doi.org/10.3390/ph19111826
Vancouver
KC B, Adhikari S, Gurung R, Kaphle HP, Sharma P, Lamshal R, et al. Inpatient Opioid Utilisation and Pain Status at Discharge in a Tertiary Hospital in Western Nepal: A Cross-Sectional Study. Pharmaceuticals. 2026;19(11):1826. doi:10.3390/ph19111826
BibTeX
@article{KC2026,
author = {KC, Bhuvan and Adhikari, Sundar and Gurung, Roshani and Kaphle, Hari Prasad and Sharma, Pratima and Lamshal, Ramesh and Shrestha, Shakti and Alrasheedy, Alian A.},
title = {Inpatient Opioid Utilisation and Pain Status at Discharge in a Tertiary Hospital in Western Nepal: A Cross-Sectional Study},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {11},
pages = {1826},
doi = {10.3390/ph19111826}
}
EUVIMED